Transcription
So, we're very bullish on AI, but we're not bullish currently on exactly where we're supposed to be and how to play it aggressively. Not unlike the internet in 2000-2001, you could have believed in the internet, not been exposed, and then got your exposure on a more timely basis. That was Stanley Druckenmiller, one of the most legendary investors of our time, wrestling with a question that's been on everyone's mind: How exactly do you play the AI Revolution?
Druckenmiller, a master of timing markets, has been incredibly bullish on AI's transformative potential. He likened it to the early days of the internet—an unstoppable force that's bound to change the world. But here's the kicker: Despite his conviction in AI, he's not rushing in blindly. He's taking a strategic step back, waiting for the dust to settle and figuring out where the real opportunities lie.
Now, let's pivot to some fascinating moves he's recently made in his latest trades. Druckenmiller exited his position in Nvidia, the powerhouse behind AI infrastructure. Yes, you heard that right—this is the same Nvidia that has become synonymous with the AI boom. He's also significantly trimmed his stake in Microsoft, another major AI player that has been riding the wave with its investments in OpenAI.
But here's the twist: just a few weeks ago, in another CNBC interview, Druckenmiller admitted he sold Nvidia too early. He openly confessed that while he's still bullish on the company, he's waiting for a better entry point— a dip that makes it worth buying again. So, why did he exit now? It's all about discipline and prioritizing where he sees more value in the current market environment.
Druckenmiller is strategically reallocating his capital, choosing not to chase AI hype at sky-high valuations, but rather seeking better risk-adjusted opportunities. And guess what? We've uncovered some of the new positions he's pivoting toward. Druckenmiller's recent 13F filing reveals five intriguing additions to his portfolio: two brand new AI stocks, a promising e-commerce play, and two significant increases in other sectors where he sees outsize potential.
In this video, we're going to break down each of these five stocks and explain why Druckenmiller might be positioning himself here for the next big move. Let's get started.
Before we dive back in, I have an exciting update to share! Over the past months, we've recommended multiple stocks that have seen remarkable gains, rewarding both our YouTube viewers and private Discord members handsomely. For instance, we highlighted IonQ when it was trading near $10, and today it's hovering around $20. We covered AppLovin at $75, and it recently soared to the $300 level. MicroStrategy we called it at $130, and it's now sitting comfortably above $300.
And that's not all! Our timely picks on SoFi, Energy Fuels, AKA Brands, TSM, and others have delivered impressive 2x to 5x returns for those who took action on our insights. The results speak for themselves, and if you missed out, here's your chance to stay ahead of the game. By joining our private Discord through Patreon, you'll gain access to timely buy and sell alerts, in-depth market analysis, and a thriving community of over 1,000 active investors. Plus, you'll be among the first to know about our upcoming penny stock pick with a potential 300% upside.
Joining us not only keeps you informed during market hours but also gives you direct access to discussions on critical market moves. The link to join is in the description below, and your support is greatly appreciated.
The first stock Druckenmiller is betting big on is none other than Broadcom Inc. (ticker symbol AVGO). This strategic addition to his portfolio has caught everyone's attention, with Druckenmiller acquiring 239,900 shares worth $41.4 million in the third quarter of 2024. And it's easy to see why he's bullish on this stock. Broadcom has been on a tear this year, gaining over 65% year-to-date, driven by surging demand for AI infrastructure and high-performance semiconductors.
But what makes Broadcom stand out right now? It's all about the long-term potential in AI. Despite a one-time tax hit that impacted its recent earnings, the company's fundamentals remain strong. They beat both earnings and revenue estimates, and the guidance suggests a massive $122 billion in revenue from AI components alone by the end of fiscal 2024. Druckenmiller's move to scoop up Broadcom shares shows he's positioning for the next wave of AI-driven growth, particularly in semiconductors—a sector that's absolutely critical for the AI Revolution.
Broadcom's investments in custom chips and its strategic acquisition of VMware are giving it an edge in this competitive landscape.
All right, let's move on to the second stock Druckenmiller is betting on: Taiwan Semiconductor Manufacturing Company Limited (ticker symbol TSM). Despite all the buzz around AI and chipmakers, Druckenmiller's decision to invest in over 57,000 shares of TSMC, valued at $1 million, shows he's taking a strategic long-term approach.
Here's why this move makes a lot of sense: TSMC is a true powerhouse in the semiconductor industry, especially when it comes to AI. The company dominates the fabrication market, producing cutting-edge chips for tech giants like Apple and Nvidia. In fact, nearly 70% of its revenue now comes from advanced 7 nanometer or smaller nodes, making TSMC the backbone of AI hardware development.
But here's the real kicker: TSMC recently reported strong results from its new Arizona plant, with yields surpassing those of its Taiwan facilities. This is huge, especially at a time when geopolitical tensions are a concern, with the US government eager to support domestic chip production. TSMC is well-positioned to secure even more backing while competitors like Intel are struggling, facing factory delays and yield issues. TSMC is expanding its moat with unmatched efficiency and scale.
With a forward P/E ratio of just under 20, TSMC offers a more attractive valuation compared to Nvidia, which is trading at significantly higher multiples. This makes it a compelling play for investors who want exposure to AI but with a more stable, predictable growth profile.
Now, let's talk about the third stock on Druckenmiller's radar: Coupang Inc. (ticker symbol CPNG). Druckenmiller has been doubling down on this South Korean e-commerce giant, adding 725,000 more shares to his portfolio, bringing his total to nearly 2.5 million shares. This position now makes up a whopping 10.6% of his entire portfolio, valued at $287.4 million. Clearly, he sees something special here, and it's not hard to see why.
Coupang is often dubbed the "Amazon of South Korea," but it's much more than that. This company has transformed itself into a one-stop shop for everything from groceries to luxury goods, and it's rapidly expanding its footprint with innovative offerings like Rocket Fresh and RLX. What sets Coupang apart is its relentless focus on customer satisfaction, supported by a debt-free balance sheet with $4.2 billion in net cash. This gives it incredible flexibility to keep growing, even in a competitive market.
But here's the real kicker: Despite a temporary dip in adjusted EBITDA margins this past quarter, Coupang's growth story remains strong. Its developing offering segment is exploding, up a staggering 146% year-over-year. Druckenmiller's increased stake signals confidence that Coupang is on track to achieve its ambitious growth targets, potentially reaching $2 billion in adjusted EBITDA by 2025.
Let's move on to the fourth stock that's caught Druckenmiller's attention: Natera Inc. (ticker symbol NTRA). Stanley Druckenmiller has made a massive bet on Natera, nearly doubling his position by adding 1.59 million shares in Q3, bringing his total holdings to over 3.5 million shares. This bold move now accounts for 6.85% of his portfolio, with a total value of $42.84 million. Clearly, Druckenmiller sees a huge upside in this precision medicine company.
Why Natera? The answer lies in its cutting-edge genomic testing technology, especially its game-changing Signatera test, which is revolutionizing cancer detection. Signatera's ability to identify molecular traces of cancer cells and provide real-time monitoring makes it an invaluable tool for oncologists. And the best part? It's a recurrent test, meaning it generates steady recurring revenue for Natera—something investors love to see.
But Natera is not stopping there. Its non-invasive Panorama test for prenatal screening and the Prospera test for transplant monitoring are also gaining significant traction. The precision medicine market is expected to skyrocket from $91 billion in 2024 to $246 billion by 2033, and Natera is positioning itself as a leader in this high-growth industry.
Finally, let's take a look at the fifth stock Druckenmiller is heavily investing in: Philip Morris International Inc. (ticker symbol PM). Druckenmiller has significantly increased his stake in Philip Morris by adding 245,000 shares, representing a substantial 27.5% increase in his position, now valued at $37.75 million.
So, what's driving this bold move into a company known primarily for its tobacco products? Well, Philip Morris is undergoing a remarkable transformation. The company is pivoting away from traditional cigarettes toward less harmful smoke-free products. Their flagship product, Zyn nicotine pouches, is gaining incredible traction, especially in the US market. Zyn's appeal lies in its versatility—no cancer risk, usability in smoke-free zones, and no FDA flavor bans like e-cigarettes face.
This strategic shift has already led to nearly 40% of Philip Morris's revenue coming from smoke-free products—a figure that's steadily climbing. But there's more to this story: despite regulatory challenges, especially with an uncertain political climate ahead, Philip Morris is rapidly expanding its production capacity for Zyn as demand far outpaces supply. The company's commitment to diversifying beyond cigarettes is finally paying off, pushing its stock to new highs in 2024, up 38% year-to-date.